The progress made by medical and pharmaceutical science over the past decades is immense, so new rules are constantly established in this area as well.

Take for example the old invention of penicillin by the field of pharmacy. There are many pharmaceutical patents and some are the commercial foundation of their existence, but also the foundation of their investments in R & D.

Many medical and pharmaceutical data are constantly scientifically examined. One or several authoritative research results may adversely affect the alleged success of the effect of a particular drug. Once a patent for a medicine has been granted, not every form of distribution or advertisement is possible unconditionally.

There are sometimes "grey" i.e. flexible rules and concepts that require specific advice before relevant statements can be made. For a pharmaceutical company that wants to develop further and to explore new markets or new forms of marketing, this is not always easy. For example, questions may arise concerning the patentability of submitted pharmaceutical inventions or the right to market products, upon registration of medicines, or having a licence issued for research and development (R & D).

This is Sliced Diazo Plone Theme